HeartSciences Inc. HSCS
Industrial Specialties · IPO 2022 · data as of November 13, 2026
HeartSciences Inc. (HSCS) is a healthcare company listed in the US with a market value of about $10M. In the twelve months to July 31, 2026 it had revenue of $4519 and net income of -$10M, a net margin of -227024.2%.
Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -835%.
About HeartSciences
HeartSciences is listed in the US and classified in industrial specialties, IPO year 2022. Revenue went from $14373 in 2022 to $4319 in 2026, a decline of about 26.0% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 3202% over three years (dilution for shareholders). It spends 65733% of revenue on research and development.
Score: 0.2 / 5
Checks passed
- Strong R&D investment or growth above 20%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | $4519 | $4319 | $4350 | $18600 | $5150 | $14373 |
| Net income | -$10M | -$9M | -$9M | -$7M | -$6M | -$5M |
| Free cash flow | — | -$7M | -$7M | -$6M | -$6M | -$4M |
| EPS (diluted) | $-2.76 | $-3.48 | $-9.34 | $-18.74 | $-80.00 | $-145.00 |
| Net margin | -227024.2% | -211700.0% | -201500.0% | -35511.9% | -123400.0% | -33592.6% |
| ROIC | — | -159.7% | -206.8% | -59.6% | -268.8% | -3477.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does HeartSciences pay a dividend?
Not currently.
Is HeartSciences a good stock to buy?
We do not give buy or sell advice. HeartSciences scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.